B

P

BEDARD , Phillipe L

Last name: BEDARD

First name: Phillipe L

2019 (v1)

Publication

Metadata-only

Lucitanib for the treatment of HR+/ HER2- metastatic breast cancer: results from the multicohort phase II FINESSE study

Hui, Rina Pearson, Alex Cortés, Javier

FGFR1 gene is amplified in 14% of HR+/ HER2- breast cancer patients. Efficacy and safety of lucitanib, an inhibitor of VEGFR1-3, FGFR1-3 and PDGFRα/β, were assessed.

Uploaded on: April 14, 2023